Hikma Starts Seeing Benefits Of Stepping In On US Shortages

 
• By Aidan Fry

Helping to alleviate shortages of critical US injectables, including controlled substances, has strengthened Hikma’s relationships with its hospital customers in the US, including with Civica Rx, CEO Siggi Olafsson told Generics Bulletin.

GPO
Group purchasing organizations are appreciating Hikma's ability to fill injectables supply gaps, CEO Siggi Olafsson says • Source: Shutterstock

More from Generics

More from Products